Abstract
Tumor-associated macrophages play a central role in tumor progression and metastasis. Macrophages can also promote the resistance of malignant cells to chemotherapy by stimulating the upregulation of cytidine deaminase, an intracellular enzyme that catabolizes the active form of gemcitabine. Targeting macrophage-dependent chemoresistance may reduce tumor-associated morbidity and mortality.
Original language | English (US) |
---|---|
Article number | e27231 |
Journal | OncoImmunology |
Volume | 2 |
Issue number | 12 |
DOIs | |
State | Published - 2013 |
Keywords
- Chemotherapy
- Cytidine deaminase
- Gemcitabine
- Macrophages
- Pancreatic ductal adenocarcinoma
- Resistance
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology